Chemoinformaics analysis of cis-Chrysanthenyl isobutyrate
| Molecular Weight | 222.328 | nRot | 2 |
| Heavy Atom Molecular Weight | 200.152 | nRig | 9 |
| Exact Molecular Weight | 222.162 | nRing | 3 |
| Solubility: LogS | -4.268 | nHRing | 0 |
| Solubility: LogP | 4.613 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 3 |
| Atoms Count | 38 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 2 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 14 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 39.6534 |
| nHD | 0 | BPOL | 24.6746 |
| QED | 0.53 |
| Synth | 4.545 |
| Natural Product Likeliness | 2.467 |
| NR-PPAR-gamma | 0.006 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.437 |
| Pgp-sub | 0.003 |
| HIA | 0.005 |
| CACO-2 | -4.409 |
| MDCK | 0.000029 |
| BBB | 0.539 |
| PPB | 0.748236 |
| VDSS | 1.462 |
| FU | 0.320383 |
| CYP1A2-inh | 0.249 |
| CYP1A2-sub | 0.124 |
| CYP2c19-inh | 0.157 |
| CYP2c19-sub | 0.836 |
| CYP2c9-inh | 0.12 |
| CYP2c9-sub | 0.165 |
| CYP2d6-inh | 0.026 |
| CYP2d6-sub | 0.372 |
| CYP3a4-inh | 0.083 |
| CYP3a4-sub | 0.34 |
| CL | 14.072 |
| T12 | 0.086 |
| hERG | 0.025 |
| Ames | 0.009 |
| ROA | 0.794 |
| SkinSen | 0.173 |
| Carcinogencity | 0.294 |
| EI | 0.128 |
| Respiratory | 0.971 |
| NR-Aromatase | 0.005 |
| Antiviral | Yes |
| Prediction | 0.886612 |